Oncotarget | Unveiling the non-canonical functions of EZH2 in prostate cancer
2023-03-03
(Press-News.org)
“In summary, both articles by Yi et al. emphasized the significance of non-canonical functions of EZH2 during PCa [prostate cancer] development [...]”
BUFFALO, NY- March 3, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on February 11, 2023, entitled, “Unveiling the non-canonical functions of EZH2 in prostate cancer.”
Prostate cancer (PCa) is ranked as the second leading cause of cancer-related death among American men excluding skin cancer. In this new editorial, researchers Yang Yi, Yanqiang Li, Kaifu Chen, and Qi Cao from Northwestern University’s Feinberg School of Medicine discuss a well-known oncogenic driver in PCa: enhancer of zeste homolog 2 (EZH2)—canonically known for the functions as the catalytic subunit of Polycomb Repressive Complex 2 (PRC2) that deposes histone H3 lysine 27 mono, di-, and tri-methylation (H3K27me1-3) and represses transcription.
“Although the oncogenic role of EZH2 mainly relies on its enzymatic activity and the PRC2, accumulating evidence suggests that targeting the lysine methyltransferase activity of EZH2 alone is ineffective in treating EZH2-dependent malignancies including PCa [4, 5].”
Hence, deeply investigating the multifaceted tumorigenic functions of EZH2 will shed new light on understanding the etiology of PCa. It is noteworthy that two recent studies published in Nature Cell Biology and Oncogene by Yi et al. described previously unrecognized roles of EZH2 in regulation of translation and coactivation of transcription, respectively. In both cases, EZH2 exerts oncogenic functions independently of PRC2 and H3K27me3 to promote tumorigenesis and aggressiveness in PCa.
“In summary, both articles by Yi et al. emphasized the significance of non-canonical functions of EZH2 during PCa development, which may provide novel insights into the advancement of EZH2-targeting strategies to treat PCa patients. In fact, a new wave has been ushed for the discovery of EZH2 inhibitors to eliminate both the catalytic and non-catalytic activities of EZH2 [12–14]. Will these newly developed EZH2 degraders be successfully applied in PCa therapy? Will additional noncanonical functions of EZH2 be characterized in the PCa model? Let’s eagerly wait and see.”
Read the full editorial: DOI: https://doi.org/10.18632/oncotarget.28357
Correspondence to: Qi Cao
Email: qi.cao@northwestern.edu
Keywords: EZH2, prostate cancer, FBL, CDCA8, E2F1
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-03-03
For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole (brand name Abilify) to an antidepressant they’re already taking is more effective than switching from one antidepressant to another, according to a new multicenter study led by Washington University School of Medicine in St. Louis.
Aripiprazole originally was approved by the FDA in 2002 as a treatment for schizophrenia but also has been used in lower doses as an add-on treatment for clinical depression ...
2023-03-03
A new white paper by the American Foregut Society recommends expanding the classification of the esophagogastric junction (EGJ) to increase an assessment of the axial hiatal hernia length, hiatal hernia aperture diameter, and presence or absence of the flap value making it more comprehensive. The white paper is published in the December issue of Foregut, the only subscription journal focused exclusively on foregut disease linking medical, endoscopic, and surgical disciplines.
Gastrointestinal reflux disease ...
2023-03-03
Research Highlights:
People who had higher scores for sleep health — based on regularity, satisfaction, alertness, timing, efficiency and duration — during a 12-month weight loss program were more likely to follow the caloric intake and exercise components of the program in comparison to peers who scored lower for sleep health.
People with better sleep health attended more of the program’s group sessions.
Embargoed until 10:15 a.m. CT/11:15 a.m. ET, Friday, March 3, 2023
DALLAS, March 3, 2023 — ...
2023-03-03
From working with Appalachian communities to examining issues of displacement for refugees, two Virginia Tech faculty have made it their life and scholarly mission to recognize the people that society often overlooks.
Now a prestigious national foundation is giving them significant resources to tell the hidden historical stories of communities throughout Southwest Virginia, an opportunity to put their passion into action.
Emily Satterwhite and Katrina Powell received a $3 million grant from the Andrew W. Mellon Foundation for a three-year project to work with communities across the state’s Appalachia region to commemorate neglected histories.
Their project, Monuments ...
2023-03-03
Washington, AAAS Annual Meeting. Imagine having a third arm – a robotic one – to assist you with daily living. Silvestro Micera from EPFL, Switzerland, is engineering the human nervous system to make this a possibility.
For decades, professor Silvestro Micera of EPFL has dedicated his research to helping people with sensory and motor deficits to re-gain independence and quality of life by developing wearable and implantable technologies. But this is changing, as he begins to explore what it means to augment the human body.
The neuroengineer has thus far avoided the subject of ...
2023-03-03
More than 500,000 people in the United States undergo rehabilitation following a stroke or brain injury every year. Movement impairments following a stroke are a major cause of adult disability in the United States, and routine treatments are not currently optimized for individual patient needs.
University of Oklahoma biomedical engineer Yuan Yang, Ph.D., has received a Faculty Early Career Development Award, known as a CAREER award, from the National Science Foundation to advance the scientific study of brain functional changes after a stroke and pioneer a tailored rehabilitation strategy that fits individual needs.
“The way a stroke victim’s brain adapts to the ...
2023-03-03
Helping caregivers take better care of themselves can improve the quality of care they provide to individuals with neurological disabilities, according to experts writing in NeuroRehabilitation
Amsterdam, March 3, 2023 – Research on caregiving after neurotrauma and neurological disability extends the focus beyond individuals with neurological conditions to caregivers - family, friends, and significant others who also are also greatly impacted. In this thematic issue published in NeuroRehabilitation, noted experts present the latest research ...
2023-03-03
Noel Bairey Merz, MD, professor of cardiology and the director of the Barbra Streisand Women’s Heart Center in the Smidt Heart Institute, will receive the 2023 Master of the ACC Award from the American College of Cardiology (ACC) in honor of her pioneering contributions to the cardiovascular profession.
She will be recognized during the ACC’s Annual Scientific Session on Monday, March 6, in New Orleans.
The Master of the ACC Award recognizes and honors ACC Fellows who have served with distinction, consistently contributing to the goals and programs ...
2023-03-03
Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond to brain and cognitive changes in Alzheimer’s disease patients.
Their analysis, published in the peer-reviewed journal Acta Neuropathologica, is an important step toward understanding the complex effects of Alzheimer’s disease on the retina, especially at the earliest stages of cognitive impairment. Experts believe this understanding is key for the development of more effective treatments that could prevent ...
2023-03-03
A study published in JAMA Network Open has found that in the US between 1999 and 2020, Black infants disproportionately died from necrotizing enterocolitis compared to White infants, despite overall improvements in the rates of death from the disease.
Necrotizing enterocolitis (NEC) is one of the most common causes of death in preterm infants. Medically-fragile term infants, such as neonates born with a congenital heart defect, are also at an elevated risk of NEC. Two prior studies reported conflicting trends in NEC rates. One study from 2000-2011 showed increasing rates of death from the condition over time. Another study reported declining rates of NEC from 2006-2017.
Researchers ...
LAST 30 PRESS RELEASES:
[Press-News.org] Oncotarget | Unveiling the non-canonical functions of EZH2 in prostate cancer
